Obesity Drug Coverage Could Boost Spending By $35B Through 2034: CBO
Go back to Obesity Drug Coverage Could Boost Spending By $35B Through 2034: CBO| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1142.85 -7 (0.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1149.85 | 52 Week High | $88.16 | |||
| Open | $1153.82 | 52 Week Low | $67.88 | |||
| Day High | $1164.92 | P/E | 264.55 | |||
| Day Low | $1136.66 | EPS | $4.32 | |||
| Volume | 2,054,259 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 37.32 -0.08 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.40 | 52 Week High | $59.00 | |||
| Open | $37.63 | 52 Week Low | $32.80 | |||
| Day High | $37.65 | P/E | N/A | |||
| Day Low | $37.17 | EPS | $0.00 | |||
| Volume | 10,326,086 | |||||
